About
We help the pharmaceutical and specialty chemical industries manufacture high value molecules by combining custom designed immobilized enzymes with continuous biomanufacturing processes.
Market Applications
What we offer
What we offer:
find out moreNovel Enzymes with Improved Performance
Enzyme Immobilization
Continuous manufacturing
Avoid lengthy R&D
Switch to biomanufacturing with our plug and play solutions
Work with us to create the solution you need
Team Testimonials
Team Testimonials
We believe the way chemicals and pharmaceuticals are created in the next ten years will be through the utilization of enzymes. Enzymes are beautiful machines found in nature that perform complex chemical transformations most chemists can only dream about. We use these natural machines to make pharmaceuticals and high value molecules allowing us to re-think chemical synthesis.
Joshua Britton
CEO
The way Debut performs pharmaceutical manufacturing and modification is truly unique. It’s an exciting time for chemical biology and continuous manufacturing.
Continuous manufacturing has the potential to drastically improve the way we make molecules. The team at Debut Biotechnology is combining state of the art continuous manufacturing technology with in-vitro biocatalysis. Nature has this incredible ability to make complex molecules and Debut is bringing this to market in a scalable and efficient manner.
We’re humbled by the amount of early interest and support we’ve received from industry partners and the broader synthetic biology community. Continuous manufacturing is the future and Debut intends to enable it.
